Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+628.7%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
387x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.10M | -15.9% |
| 2024 | $9.64M | +1505.5% |
| 2023 | $600192.00 | +2766.1% |
| 2022 | $20941.00 | +79.9% |
| 2021 | $11639.00 | - |